Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia
Crossref DOI link: https://doi.org/10.1007/s00508-016-1124-4
Published Online: 2016-11-23
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Huemer, Florian
Dejaco, Martin
Grabmer, Christoph
Melchardt, Thomas
Neureiter, Daniel
Mayer, Georg
Egle, Alexander
Greil, Richard
Weiss, Lukas
License valid from 2016-11-23